Pitfalls of using the risk ratio in meta-analysis

被引:43
|
作者
Bakbergenuly, Ilyas [1 ]
Hoaglin, David C. [2 ]
Kulinskaya, Elena [1 ]
机构
[1] Univ East Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
关键词
beta-binomial model; log-binomial model; relative risk; response ratio; risk difference; BINARY OUTCOMES METHODS; RELATIVE RISK; CLINICAL-TRIALS; ABSOLUTE RISK; BINOMIAL MODEL; HETEROGENEITY; VARIANCE; BIAS; DIFFERENCE; REGRESSION;
D O I
10.1002/jrsm.1347
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
For meta-analysis of studies that report outcomes as binomial proportions, the most popular measure of effect is the odds ratio (OR), usually analyzed as log(OR). Many meta-analyses use the risk ratio (RR) and its logarithm because of its simpler interpretation. Although log(OR) and log(RR) are both unbounded, use of log(RR) must ensure that estimates are compatible with study-level event rates in the interval (0, 1). These complications pose a particular challenge for random-effects models, both in applications and in generating data for simulations. As background, we review the conventional random-effects model and then binomial generalized linear mixed models (GLMMs) with the logit link function, which do not have these complications. We then focus on log-binomial models and explore implications of using them; theoretical calculations and simulation show evidence of biases. The main competitors to the binomial GLMMs use the beta-binomial (BB) distribution, either in BB regression or by maximizing a BB likelihood; a simulation produces mixed results. Two examples and an examination of Cochrane meta-analyses that used RR suggest bias in the results from the conventional inverse-variance-weighted approach. Finally, we comment on other measures of effect that have range restrictions, including risk difference, and outline further research.
引用
收藏
页码:398 / 419
页数:22
相关论文
共 50 条
  • [31] Prediabetes and the risk of cancer: a meta-analysis
    Yi Huang
    Xiaoyan Cai
    Miaozhen Qiu
    Peisong Chen
    Hongfeng Tang
    Yunzhao Hu
    Yuli Huang
    Diabetologia, 2014, 57 : 2261 - 2269
  • [32] Inadequacies and pitfalls of network meta-analysis applied to femoropopliteal endovascular interventions
    Sobreira, Marcone Lima
    Malgor, Rafael D.
    VASCULAR, 2021, 29 (02) : 311 - 312
  • [33] Meta-Analysis of Rivaroxaban and Bleeding Risk
    Wasserlauf, Guila
    Grandi, Sonia M.
    Filion, Kristian B.
    Eisenberg, Mark J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (03): : 454 - 460
  • [34] Depression and Risk for Diabetes: A Meta-Analysis
    Yu, Min
    Zhang, Xingliang
    Lu, Feng
    Fang, Le
    CANADIAN JOURNAL OF DIABETES, 2015, 39 (04) : 266 - 272
  • [35] Smoking and risk of meningioma: A meta-analysis
    Fan, Zuoxu
    Ji, Tao
    Wan, Shu
    Wu, Yaoyao
    Zhu, Yu
    Xiao, Feng
    Zhan, Renya
    CANCER EPIDEMIOLOGY, 2013, 37 (01) : 39 - 45
  • [36] Smoking and risk of glioma: a meta-analysis
    Mandelzweig, Lori
    Novikov, Ilya
    Sadetzki, Siegal
    CANCER CAUSES & CONTROL, 2009, 20 (10) : 1927 - 1938
  • [37] Obesity and the risk of cholangiocarcinoma: a meta-analysis
    Li, Jun-Shan
    Han, Tian-Jie
    Jing, Nie
    Li, Lei
    Zhang, Xiao-Hua
    Ma, Feng-Zhen
    Liu, Ji-Yong
    TUMOR BIOLOGY, 2014, 35 (07) : 6831 - 6838
  • [38] Thiazolidinediones and the risk of edema: A meta-analysis
    Berlie, Helen D.
    Kalus, James S.
    Jaber, Linda A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (02) : 279 - 289
  • [39] Relative Risk Aversion: A Meta-Analysis
    Elminejad, Ali
    Havranek, Tomas
    Irsova, Zuzana
    JOURNAL OF ECONOMIC SURVEYS, 2025,
  • [40] Smoking and fracture risk: A meta-analysis
    Kanis, JA
    Johnell, O
    Oden, A
    Johansson, H
    De Laet, C
    Eisman, JA
    Fujiwara, S
    Kroger, H
    McCloskey, EV
    Mellstrom, D
    Melton, LJ
    Pols, H
    Reeve, J
    Silman, A
    Tenenhouse, A
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S10 - S10